Delivery Order SPE2DE24DA010-SPE2D626F40JY
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award (Contract No. 4570376636, designated "GALLANT") from the Defense Logistics Agency Medical Supply Chain on December 30, 2025, with a ceiling value of $37,127.95 and an ultimate completion date of January 5, 2026. The contract utilizes a fixed-price structure with economic price adjustment pricing and will be performed in Santa Clara, California. No set-aside designation was used in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $38,645.80 under contract number 4570509253 (GALLANT) from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026. The delivery order utilizes a fixed price with economic price adjustment pricing structure and carries no set-aside designation, reflecting Abbott's competitive positioning in federal healthcare procurement. Performance is scheduled for completion by January 20,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $36,320.80 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This delivery order, designated as GALLANT (Contract Number 4569403310), was issued without set-aside provisions, indicating full and open competition. The contract will be performed in Santa Clara, California, with an ultimate completion date of September 15,...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a $34,732.80 fixed-price delivery order (Contract No. 4570178737, "GALLANT") from the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with completion scheduled for December 4, 2025. The award, issued through full and open competition with no set-aside designation, supports the agency's medical supply procurement operations at Abbott's Santa Clara, California facility. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $60,563.90 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of September 19, 2025. The contract, designated as GALLANT (Contract Number 4569469210), was awarded without a set-aside designation, indicating full and open competition. The place of performance is located in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order on December 31, 2025, under contract number 4570556639 (GALLANT) with a fixed ceiling value of $25,875.85. This delivery order, issued by the Defense Logistics Agency's Medical Supply Chain, represents a continuation of Abbott's substantial federal contracting presence in cardiovascular medical technologies. The award carries no set-aside designation and was issued under a fixed-price structure with...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $21,147 fixed-price delivery order (Contract 4570006266, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. The delivery order, issued without any small business set-aside, is for performance at Abbott's Santa Clara, California location. This award represents a task order under Abbott's established relationship with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $25,875.85 fixed-price delivery order (Contract No. 4570444146, GALLANT) by the Defense Logistics Agency Medical Supply Chain on January 8, 2026, with performance completion targeted for January 13, 2026. The award was made without set-aside designation through full and open competition and will be performed in Santa Clara, California. This delivery order represents a discrete procurement action under Abbott's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a $34,732.80 fixed-price delivery order (Contract 4570380875, GALLANT) from the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with completion targeted for January 6, 2026. The delivery order, issued without set-aside designation, will be performed in Santa Clara, California, and represents a task order execution under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $25,875.85 on December 11, 2025, under a fixed-price contract with economic price adjustment terms. The award, designated as contract number 4570382323 (GALLANT), is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused procurement entity supporting the Department of Defense's medical device and equipment requirements. The place of performance is located...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F40JYDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $21,425 from the Defense Logistics Agency's Medical Supply Chain on January 8, 2026, with completion scheduled for February 6, 2026. The contract, designated 4570718001 GALLANT, utilizes fixed-price pricing with economic price adjustment mechanisms and requires performance at Abbott's facility in Santa Clara, California. This delivery order was awarded through full and open competition with no set-aside designation, reflecting Abbott's competitive positioning as a qualified federal contractor within the DLA's cardiovascular medical technology procurement framework. This award represents a discrete task order under the Defense Logistics Agency's broader medical supply chain contracting vehicle, through which Abbott Vascular has established itself as a primary supplier of advanced cardiovascular devices and procedural packages to federal healthcare systems. The relatively modest ceiling value is consistent with individual delivery orders drawn from the DLA's comprehensive indefinite delivery contract with Abbott, valued at $117.1 million, which provides flexible procurement of cardiovascular surgical implants, instrumentation, accessories, and related medical technologies supporting both military and veteran healthcare operations. Abbott's substantial federal contracting portfolio demonstrates ongoing capacity to deliver specialized cardiovascular medical devices and support services essential to the Department of Defense and Department of Veterans Affairs healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 1/7/26 |